Table 1 Clinical characteristics of the patients in the training and test groups
From: Research on multi-model imaging machine learning for distinguishing early hepatocellular carcinoma
Features | The group of HCC(n = 97) | The group of non-HCC (n = 124) | The test value (H-value) | P-value | |
|---|---|---|---|---|---|
Malignant group (n = 30) | Benign group (n = 94) | ||||
Age(year)Mean(SD) | 57.64(9.1) | 53.17(11.5) | 58.83(11.7) | 3.237 | 0.041 |
The maximum diameter of the tumor (mm)M(IQR) | 35.0(23.5,58.5) | 40.5(25.0,66.25) | 25.5(15.75,50.25) | 11.6 | 0.003 |
Gender(%) |  |  |  | 16.702 | < 0.001 |
Male | 78(80.4) | 13(43.3) | 58(61.7) | Â | Â |
Female | 19(19.6) | 17(56.7) | 36(38.3) | Â | Â |
Cirrhosis(%) | Â | Â | Â | 73.794 | <0.001 |
Yes | 79(81.4) | 5(16.7) | 24(25.5) | Â | Â |
No | 18(18.6) | 25(83.3) | 70(74.5) | Â | Â |
Place (%) | Â | Â | Â | 2.967 | 0.227 |
Right lobe | 85(87.6) | 23(76.7) | 75(79.8) | Â | Â |
Left lobe | 12(12.4) | 7(23.3) | 19(20.2) | Â | Â |
Capsule(%) | Â | Â | Â | 66.913 | <0.001 |
Yes | 80(82.4) | 8(26.7) | 25(26.6) | Â | Â |
No | 17(17.6) | 22(73.3) | 69(73.4) | Â | Â |
Significant enhancement of the arterial phase (%) | Â | Â | Â | 39.442 | <0.001 |
Yes | 95(97.9) | 20(66.7) | 58(61.7) | Â | Â |
No | 2(2.1) | 10(33.3) | 36(38.3) | Â | Â |
Contouring(%) | Â | Â | Â | 84.099 | <0.001 |
Yes | 86(88.6) | 7(23.3) | 26(27.7) | Â | Â |
No | 11(11.4) | 23(76.7) | 68(72.3) | Â | Â |
Uniform (%) | Â | Â | Â | 62.951 | <0.001 |
Yes | 5(5.1) | 10(33.3) | 58(61.7) | Â | Â |
No | 92(94.9) | 20(66.7) | 36(38.3) | Â | Â |
Steatosis(%) | Â | Â | Â | 42.876 | <0.001 |
Yes | 72(74.2) | 4(13.3) | 37(39.4) | Â | Â |
No | 25(25.8) | 26(86.7) | 57(60.6) | Â | Â |